Literature DB >> 19349481

Unprotected sex following HIV testing among women in Uganda and Zimbabwe: short- and long-term comparisons with pre-test behaviour.

Abigail Norris Turner1, William C Miller, Nancy S Padian, Jay S Kaufman, Frieda M Behets, Tsungai Chipato, Francis A Mmiro, Robert A Salata, Charles S Morrison.   

Abstract

BACKGROUND: Despite widespread condom promotion for HIV prevention, prospective measurement of condom use before and after HIV testing is infrequent.
METHODS: We analysed data from a prospective study of hormonal contraception and HIV acquisition among Zimbabwean and Ugandan women (1999-2004), in which HIV testing and counselling were performed approximately every 3 months. We used zero-inflated negative binomial (ZINB) models to examine the number and proportion of unprotected sex acts, comparing behaviour reported 2-6 months before HIV testing with behaviour reported both 2-6 months (short-term analysis) and 12-16 months (long-term analysis) after HIV testing.
RESULTS: Short- and long-term analyses were similar, so we present only long-term findings from 151 HIV-infected and 650 uninfected participants. The proportion of HIV-infected women reporting any unprotected acts in a typical month declined from 74% (pre-infection behaviour) to 56% (12-16 months after HIV diagnosis). In multivariable models, HIV-infected women were twice as likely to report that all sex acts were protected by condoms after diagnosis compared with beforehand [adjusted odds ratio (aOR): 1.99, 95% confidence interval (CI): 1.12-3.53]; uninfected women were somewhat less likely to report that all acts were protected (aOR: 0.82, 95% CI: 0.64-1.04). HIV-infected women also reduced their number of unprotected acts by 38% (95% CI: -16 to -55%). However, their proportion of unprotected acts changed little (7% reduction, 95% CI: -18 to + 6%). Uninfected women reported little change in number or proportion of unprotected acts over the same time period.
CONCLUSIONS: HIV-infected women reduced the number, but not the proportion, of unprotected acts. HIV-negative women did not increase condom use after testing and counselling, but neither did they decrease condom use, suggesting that testing negative was not interpreted as endorsement of risky behaviour.

Entities:  

Mesh:

Year:  2009        PMID: 19349481      PMCID: PMC2720394          DOI: 10.1093/ije/dyp171

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  13 in total

1.  Developing an evidence-based, preventive care package for persons with HIV in Africa.

Authors:  Jonathan Mermin; Rebecca Bunnell; John Lule; Alex Opio; Amanda Gibbons; Mark Dybul; Jonathan Kaplan
Journal:  Trop Med Int Health       Date:  2005-10       Impact factor: 2.622

2.  HIV prevention for a threatened continent: implementing positive prevention in Africa.

Authors:  Rebecca Bunnell; Jonathan Mermin; Kevin M De Cock
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

Review 3.  Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials.

Authors:  Nicole Crepaz; Cynthia M Lyles; Richard J Wolitski; Warren F Passin; Sima M Rama; Jeffrey H Herbst; David W Purcell; Robert M Malow; Ron Stall
Journal:  AIDS       Date:  2006-01-09       Impact factor: 4.177

4.  Causal diagrams for epidemiologic research.

Authors:  S Greenland; J Pearl; J M Robins
Journal:  Epidemiology       Date:  1999-01       Impact factor: 4.822

5.  Hormonal contraception and the risk of HIV acquisition.

Authors:  Charles S Morrison; Barbra A Richardson; Francis Mmiro; Tsungai Chipato; David D Celentano; Joanne Luoto; Roy Mugerwa; Nancy Padian; Sungwal Rugpao; Joelle M Brown; Peter Cornelisse; Robert A Salata
Journal:  AIDS       Date:  2007-01-02       Impact factor: 4.177

6.  Simulation study of confounder-selection strategies.

Authors:  G Maldonado; S Greenland
Journal:  Am J Epidemiol       Date:  1993-12-01       Impact factor: 4.897

7.  Repeat HIV testing: high-risk behaviour or risk reduction strategy?

Authors:  S Leaity; L Sherr; H Wells; A Evans; R Miller; M Johnson; J Elford
Journal:  AIDS       Date:  2000-03-31       Impact factor: 4.177

Review 8.  The effects of HIV counseling and testing on risk-related practices and help-seeking behavior.

Authors:  R J Wolitski; R J MacGowan; D L Higgins; C M Jorgensen
Journal:  AIDS Educ Prev       Date:  1997-06

9.  Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997.

Authors:  L S Weinhardt; M P Carey; B T Johnson; N L Bickham
Journal:  Am J Public Health       Date:  1999-09       Impact factor: 9.308

10.  HIV prevalence, previous HIV testing, and condom use with clients and regular partners among Senegalese commercial sex workers.

Authors:  C Wang; S E Hawes; A Gaye; P S Sow; I Ndoye; L E Manhart; A Wald; C W Critchlow; N B Kiviat
Journal:  Sex Transm Infect       Date:  2007-10-17       Impact factor: 3.519

View more
  18 in total

1.  Study designs fail to represent the intricate effects of HIV testing and counselling on condom use and HIV transmission in sub-Saharan Africa.

Authors:  Stéphane Helleringer; Georges Reniers
Journal:  Int J Epidemiol       Date:  2010-05-10       Impact factor: 7.196

2.  Sexually transmitted infections among young men who have sex with men: Experiences with diagnosis, treatment, and reinfection.

Authors:  Brian A Feinstein; Trey V Dellucci; Simon Graham; Jeffrey T Parsons; Brian Mustanski
Journal:  Sex Res Social Policy       Date:  2017-12-11

3.  Changes in HIV risk behavior and seroincidence among clients presenting for repeat HIV counseling and testing in Moshi, Tanzania.

Authors:  Suzanne P Fiorillo; Keren Z Landman; Alison C Tribble; Antipas Mtalo; Dafrosa K Itemba; Jan Ostermann; Nathan M Thielman; John A Crump
Journal:  AIDS Care       Date:  2012-03-01

Review 4.  Serosorting and the evaluation of HIV testing and counseling for HIV prevention in generalized epidemics.

Authors:  Georges Reniers; Stéphane Helleringer
Journal:  AIDS Behav       Date:  2011-01

Review 5.  Family-centred approaches to the prevention of mother to child transmission of HIV.

Authors:  Theresa S Betancourt; Elaine J Abrams; Ryan McBain; Mary C Smith Fawzi
Journal:  J Int AIDS Soc       Date:  2010-06-23       Impact factor: 5.396

6.  Reactions to Testing HIV Negative: Measurement and Associations with Sexual Risk Behaviour Among Young MSM Who Recently Tested HIV Negative.

Authors:  Brian A Feinstein; Brent A Johnson; Jeffrey T Parsons; Brian Mustanski
Journal:  AIDS Behav       Date:  2017-05

7.  Testing negative means I'm lucky, making good choices, or immune: diverse reactions to HIV test results are associated with risk behaviors.

Authors:  Brian Mustanski; H Jonathon Rendina; George J Greene; Patrick S Sullivan; Jeffrey T Parsons
Journal:  Ann Behav Med       Date:  2014-12

8.  HIV testing and counseling leads to immediate consistent condom use among South African stable HIV-discordant couples.

Authors:  Nora E Rosenberg; Audrey E Pettifor; Guy De Bruyn; Daniel Westreich; Sinead Delany-Moretlwe; Frieda Behets; Suzanne Maman; David Coetzee; Mercy Kamupira; William C Miller
Journal:  J Acquir Immune Defic Syndr       Date:  2013-02-01       Impact factor: 3.731

9.  Determinants of condom uptake among HIV voluntary counselling and testing clients: experiences from a hospital-based study in south India.

Authors:  Rebecca Myerson; Susanna M Makela; C Chandrasekhar; Siju Mathew; Sourabh Chakraborty
Journal:  BMC Health Serv Res       Date:  2012-01-11       Impact factor: 2.655

10.  Progress Toward the 90-90-90 HIV Targets in Zimbabwe and Identifying Those Left Behind.

Authors:  Avi J Hakim; Beth A Tippett Barr; Steven Kinchen; Godfrey Musuka; Julius Manjengwa; Shungu Munyati; Lovemore Gwanzura; Owen Mugurungi; Getrude Ncube; Suzue Saito; Bharat S Parekh; Hetal Patel; Yen T Duong; Elizabeth Gonese; Katrina Sleeman; Leala Ruangtragool; Jessica Justman; Amy Herman-Roloff; Elizabeth Radin
Journal:  J Acquir Immune Defic Syndr       Date:  2021-11-01       Impact factor: 3.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.